CEPHEA VALVE TECHNOLOGIES
Cephea Valve Technologies, Inc. provides catheter delivered mitral valve regurgitation products/heart valves for the treatment of coronary artery disease in patients. It offers catheter based therapies, such as balloons and stents for aortic valves replacements. The company was incorporated in 2011 and is based in San Jose, California.
CEPHEA VALVE TECHNOLOGIES
Industry:
Health Care Medical Therapeutics
Founded:
2011-01-01
Address:
San Jose, California, United States
Country:
United States
Website Url:
http://www.cephea.com
Total Employee:
1+
Status:
Active
Total Funding:
21.21 M USD
Technology used in webpage:
SPF Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.cephea.com
- Host name: 156.234.94.53
- IP address: 156.234.94.53
- Location: Central Hong Kong
- Latitude: 22.2909
- Longitude: 114.15
- Timezone: Asia/Hong_Kong
More informations about "Cephea Valve Technologies"
Cephea Valve Technologies - Crunchbase Company …
Cephea Valve Technologies, Inc. provides catheter delivered mitral valve regurgitation products/heart valves for the treatment of coronary artery disease in patients. It offers catheter based therapies, such as balloons and stents for …See details»
Cephea Company Profile 2024: Valuation, Investors, …
Cephea General Information Description. Developer of a mitral valve replacement technology intended to treat patients with mitral valve disease. The company's technology entails delivering the valve replacement through an artificial valve …See details»
Cephea Valve Technologies Inc - Company Profile and News
Company profile page for Cephea Valve Technologies Inc including stock price, company news, executives, board members, and contact informationSee details»
Abbott To Acquire Cephea Valve Technologies, Inc.
ABBOTT PARK, Ill., Jan. 16, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held …See details»
Cephea Valve Technologies - Funding, Financials, …
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 12, 2015: Venture Round - Cephea Valve Technologies — obfuscated. …See details»
Cephea Valve Technologies | San Jose, CA, USA Startup …
Cephea Valve Technologies is developing an innovative approach to anchor a tissue mitral valve to the native mitral valve annulus. We will enable Cardiologists to deliver this mitral valve through a catheter in a much less invasive manner. …See details»
Cephea Valve Technologies - Updates, News, Events, Signals
Aug 17, 2023 Organization. Cephea Valve Technologies . Connect to CRM . Save . Summary. Financials. People. Technology. ... Growth Insight Details. Powered by AI . Edit Growth Insight …See details»
Abbott snaps up replacement mitral valve maker Cephea
Jan 18, 2019 "The acquisition of Cephea builds on Abbott's strong position in structural heart therapies and is consistent with our strategy to develop comprehensive treatments for people with mitral valve ...See details»
Cephea Valve Technologies - UCSF Rosenman Institute
Sep 25, 2020 Cephea Valve Technologies Internship Hosts Development of a less-invasive heart valve replacement technology to help treat patients suffering from mitral valve disease.See details»
Abbott inks Cephea buyout to boost mitral valve pipeline
Jan 17, 2019 While Cephea is the latest in a string of mitral valve takeovers, competition for the transcatheter repair and replacement market is just getting started. Boston Scientific, which …See details»
First-in-Human Implant of the Cephea Transseptal …
Sep 12, 2019 The great majority of TMVR technologies under investigation use either transapical access 1 or the transseptal approach via dedicated multistep anchoring systems. 2,3 In this article, we report the first-in-human implant of a …See details»
Transcatheter Mitral Valve Replacement in the Transcatheter Aortic ...
Nov 7, 2019 The Cephea (Cephea Valve Technologies) system is a frame structure valve designed for TMVR with multilevel conformability, with low device profile to permit an …See details»
Cephea Valve Technologies - CB Insights
Explore {Cephea Valve Technologies's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Cephea Valve …See details»
Transcatheter Mitral Valve Implantation: Current Status and Future ...
Aug 19, 2021 The Cephea system (Cephea Valve Technologies) has a dual-frame design allowing conformability to variable anatomies. It is fully repositionable and recapturable and it …See details»
Abbott to Broaden Foundation in Structural Heart Therapies with …
Jul 30, 2015 The Tendyne and Cephea valve replacement technologies are designed to be implanted in a beating heart, without the need for open heart surgery, similar to MitraClip, …See details»
Early Experience With a Novel Transfemoral Mitral Valve …
Oct 26, 2020 Objectives: The aim of this study was to evaluate the feasibility, procedural results, and 6-month outcomes of a novel transfemoral transcatheter mitral valve implantation (TMVI) …See details»
Cephea Early Feasibility Study
The purpose of this study is to evaluate an investigational device called the Cephea Mitral Valve System, which is designed for the treatment of a diseased, damaged, or malfunctioning mitral …See details»
Circulation: Cardiovascular Interventions - AHA/ASA Journals
Transseptal TMVR system (Cephea Valve Technologies, Santa Cruz, CA) in a preclinical model. METHODS The data that support the findings of this study are available from the …See details»
Early Experience With a Novel Transfemoral Mitral Valve …
Oct 26, 2020 The Cephea TMVI system consists of a self-expanding Nitinol double-disc structure and a central bovine trileaflet valve (Figures 1A to 1C). The valve displays a surgical …See details»
Transcatheter Mitral Valve Replacement: Current Evidence and …
May 10, 2021 The Cephea TMVR system (Abbott Vascular) is designed for transseptal delivery and consists of a self-expanding double-disc stent structure carrying a trileaflet pericardial valve.See details»